Crisaborole for treating mild to moderate atopic dermatitis in people 2 years and older (terminated appraisal)

  • Technology appraisal
  • TA701
  • Published: 

History

Documents created during the development process.

Declaration of interests

Draft guidance: 1

Invitation to participate

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators